CTMX
NASDAQStockCytomX Therapeutics, Inc.
$4.70-0.17 (-3.59%)
52-Week Range
$0.43
$6.09
Key Stats
Market Cap
795.5M
P/E Ratio
—
Dividend Yield
—
Beta
2.48
Volume
2.3M
Avg Volume
2.7M
Performance
1M
-10.31%
3M
+17.92%
6M
+144.72%
YTD
+14.59%
1Y
+649.69%
3Y
+151.03%
5Y
-44.41%
Price Chart
ETF Exposure
CTMX is held by 45 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| FDM | First Trust Dow Jones Select MicroCap Index Fund | 0.93% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.90% |
| FMED | FIDELITY DISRUPTIVE MEDICINE ETF | 0.79% |
| IDNA | iShares Genomics Immunology and Healthcare ETF | 0.65% |
| QQQS | Invesco NASDAQ Future Gen 200 ETF | 0.55% |
| CANC | Tema Oncology ETF | 0.54% |
| CURE.AX | Global X - S&P Biotech ETF | 0.29% |
| XBI | State Street SPDR S&P Biotech ETF | 0.29% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.06% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.06% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.06% |
| PWS | Pacer WealthShield ETF | 0.06% |
| STSB | iShares Factors US Small Blend Style ETF | 0.06% |
| IBB | iShares Biotechnology ETF | 0.05% |
| EES | WisdomTree U.S. SmallCap Fund | 0.05% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.05% |
| TECB | iShares U.S. Tech Breakthrough Multisector ETF | 0.01% |
| VHT | Vanguard Health Care ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| DFAS | Dimensional - US Small Cap ETF | 0.01% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.01% |
| IUSN.DE | iShares MSCI World Small Cap UCITS ETF | 0.01% |
| WSML | iShares MSCI World Small-Cap ETF | 0.01% |
| WSML.L | iShares MSCI World Small Cap UCITS ETF | 0.01% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| DXUV | Dimensional - US Vector Equity ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| USFM.L | UBS MSCI USA Select Factor Mix UCITS ETF USD dis | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
| XEQT.TO | iShares Core Equity ETF Portfolio | 0.00% |
| XUU.TO | iShares Core S&P U.S. Total Market Index ETF | 0.00% |
| DFUS | Dimensional - US Equity Market ETF | 0.00% |
| DFUV | Dimensional - US Marketwide Value ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
About CTMX ETF Exposure
CytomX Therapeutics, Inc. (CTMX) is held by 45 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 795.5M, CTMX is a widely held institutional stock. The stock currently trades at $4.70. Investors can gain exposure to CTMX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CTMX, sorted by portfolio weight.